Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Beats Revenue Estimates

Ionis Pharmaceuticals (IONS) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $1.15. This compares to a loss of $0.95 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +46.96%. A quarter ago, it was expected that this drug discovery and development company would post earnings of $0.27 per share when it actually produced earnings of $0.86, delivering a surprise of +218.52%.Over th ...